SCHEMBL345223

SCHEMBL345223

C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1OC(Oc2cc(O)c3c(c2)OC(c2ccc(O)cc2)CC3=O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLCO2B1 O94956 4/20 0.66
PTPN1 P18031 3/20 0.66
SYNJ2 O15056 1/20 0.57
CYP19A1 P11511 4/20 0.56
GSK3B P49841 3/20 0.56
UBE2N P61088 1/20 0.56
TDP1 Q9NUW8 3/20 0.56
ALDH1A1 P00352 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
MAPT P10636 1/20 0.56
ATM Q13315 1/20 0.56
TAS2R31 P59538 1/20 0.56
KDM1A O60341 2/20 0.55
DPP4 P27487 2/20 0.53
CALM1 P0DP23 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
POLB P06746 1/20 0.51
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309045 0.92 CYP1A1 (0.56) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
SCHEMBL5341486 0.90 KDM1A (0.70) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
SCHEMBL5351925 0.86 KDM1A (0.57) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
SCHEMBL29715849 0.83 PTPN1 (0.83) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
SCHEMBL4219129 0.81 CYP19A1 (0.57) CYP19A1MAPTCYP3A4
Prunin SCHEMBL318230 0.79 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
Prunin SCHEMBL2532187 0.79 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
Prunin SCHEMBL1122487 0.79 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
Prunin SCHEMBL318229 0.79 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B
Prunin SCHEMBL13625098 0.79 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2CYP19A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006024545-A1 FUSED BICYCLIC NATURAL COMPOUNDS AND THEIR USE AS INHIBITORS OF PARP AND PARP-MEDIATED INFLAMMATORY PROCESSES STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) 2006-03-09 WO claimed
JP-60069003-A None JP disclosed
EP-3827675-B1 TOBACCO MATERIAL PRODUCTION METHOD, TOBACCO MATERIAL, TOBACCO FLAVOR LIQUID PRODUCTION METHOD, TOBACCO FLAVOR LIQUID, AND HEATING-TYPE FLAVOR INHALER JAPAN TOBACCO INC (JP) 2025-09-03 EP disclosed
EP-4608876-A2 ENDOCYTIC AGENTS BioVentures, LLC (US) 2025-09-03 EP disclosed
WO-2024092274-A2 ENDOCYTIC AGENTS BIOVENTURES, LLC (US) 2024-05-02 WO disclosed
US-11234918-B2 Methods for botanical and/or algae extraction BASF CORPORATION (US) 2022-02-01 US disclosed
EP-3827675-A1 TOBACCO MATERIAL PRODUCTION METHOD, TOBACCO MATERIAL, TOBACCO FLAVOR LIQUID PRODUCTION METHOD, TOBACCO FLAVOR LIQUID, AND HEATING-TYPE FLAVOR INHALER Japan Tobacco Inc. (JP) 2021-06-02 EP disclosed
EP-1913073-B2 OIL-IN-WATER EMULSIONS HENKEL AG & CO KGAA (DE) 2020-10-14 EP disclosed
WO-2020021599-A1 TOBACCO MATERIAL PRODUCTION METHOD, TOBACCO MATERIAL, TOBACCO FLAVOR LIQUID PRODUCTION METHOD, TOBACCO FLAVOR LIQUID, AND HEATING-TYPE FLAVOR INHALER 日本たばこ産業株式会社 2020-01-30 WO disclosed
EP-2545896-B1 Sunscreen compositions HENKEL AG & CO KGAA (DE) 2019-10-16 EP disclosed
EP-0945128-A2 Use of flavones, flavanones, or flavonoides for the protection of ascorbic acid and/or ascorbylbonds against oxidation Beiersdorf Aktiengesellschaft (DE) 1999-09-29 EP disclosed
EP-0945126-A2 Cosmetic or dermatologic composition containing carnitine and/or an acylcarnitine and at least an antioxidant Beiersdorf Aktiengesellschaft (DE) 1999-09-29 EP disclosed
WO-1999037794-A1 METHODS AND COMPOSITION FOR MODULATING FLAVONOID CONTENT UNILEVER PLC (GB) 1999-07-29 WO disclosed
EP-0911019-A1 Deodorizing compositions based on flavone derivatives and/or flavanone derivatives, especially flavonoids Beiersdorf Aktiengesellschaft (DE) 1999-04-28 EP disclosed
EP-0871717-A1 beta-GLUCOSIDASE FROM FILAMENTOUS FUNGI, AND USES THEREOF INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (I.N.R.A.) (FR) 1998-10-21 EP disclosed
WO-1997002341-A1 β-GLUCOSIDASE FROM FILAMENTOUS FUNGI, AND USES THEREOF INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE - I.N.R.A. (FR) 1997-01-23 WO disclosed
EP-0052086-B1 PROCESS FOR PRODUCING FLAVONE DERIVATIVES WITH MEDICINAL ACTIVITY BONOMELLI S.p.A. (IT) 1986-01-29 EP disclosed
US-4514427-A ION EXCHANGING USING A CATIONIC STYRENE POLYMER MITCO WATER LABORATORIES INC. (US) 1985-04-30 US disclosed
JP-S6069003-A CONTROLLER FOR PLANT BLIGHT RIKAGAKU KENKYUSHO 1985-04-19 JP disclosed
EP-0052086-A1 Process for producing flavone derivatives with medicinal activity BONOMELLI S.p.A. (IT) 1982-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11234918-B2 Methods for botanical and/or algae extraction ALG1, ALG8, CUTA SLCO2B1 4826/4885PTPN1 4794/4885SYNJ2 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.